Prøve GULL - Gratis
India’s EM outperformance slows, China stages comeback
Business Standard
|October 30, 2025
The Indian stock market, which led emerging market (EM) performance for much of the past decade, is now witnessing a phase of relative consolidation with peers such as China and Taiwan staging a strong comeback.
Analysts, however, said that fiscal and monetary support, along with a rising domestic investor base and strong returns, position the market for renewed momentum.
In the past 12 months, the MSCI China has surged 35 per cent, the MSCI EM has advanced 26 per cent, while MSCI India was nearly flat in dollar terms.
The latest underperformance comes after strong gains over the past five years. Between October 2020 and October 2025, the domestic equities rose 13.7 per cent annually, while the MSCI EM managed to rise just § per cent. Meanwhile, between October 2015 and October 2020, the MSCI EM outpaced India with gains of 5.4 per cent versus 3.6 per cent.
Denne historien er fra October 30, 2025-utgaven av Business Standard.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Business Standard
Business Standard
Govt may open bids to onboard 15K Nvidia GPUs
The Centre is likely to soon open another round of bidding to onboard about 12,000-15,000 B100 and B200 graphic processing units (GPUs) from Nvidia under the IndiaAI Mission, sources told Business Standard on Thursday.
2 mins
January 09, 2026
Business Standard
Journeys in the Chinese imperium
In The Edge of the Empire: A Family’s Reckoning with China Edward Wong, journalist with The New York Times, writes about his and his father’s journeys in and away from China and how they shaped their understanding of the country as well as of each other.
3 mins
January 09, 2026
Business Standard
India may face 500% US tariff over purchase of Russian oil
Trump backs Bill aimed at punishing countries buying Russian crude
2 mins
January 09, 2026
Business Standard
Review benefit illustration, premium table, surrender value clause before purchase
Even as overall grievances against life insurers stayed flat, complaints linked to unfair business practices (UFBP) rose, going from 23,335 in 2023-24 to 26,667 in 2024-25, an increase of 14.3 per cent, according to the Insurance Regulatory and Development Authority of India’s (Irdai) annual report for 2024-25.
2 mins
January 09, 2026
Business Standard
World's copper crunch likely to intensify on AI, defence spending
The race for artificial intelligence (AI) and surging defence spending are set to intensify a projected shortage of copper as producers struggle to expand, according to a new study by S&P Global.
2 mins
January 09, 2026
Business Standard
Indices fall 1% on tariff uncertainty
Indian equity benchmarks Sensex and Nifty posted their steepest one-day drop in more than four months amid heightened uncertainty over US trade tariffs.
2 mins
January 09, 2026
Business Standard
India likely to grow at 6.6% in FY27: UN
India’s economy is projected to grow at 6.6 per cent in 2026-27 (FY27), supported by resilient consumption and strong public investment, which should largely offset the adverse impact of higher US tariffs, the United Nations (UN) said on Thursday.
1 mins
January 09, 2026
Business Standard
Premiumisation may have driven Q3 realty growth
Top listed real estate developers are expected to deliver a healthy performance in terms of presales and earnings forthe third quarter of 2025-26 (Q3FY26), supported by festival demand, resilient buyer sentiment, steady launches, premium sales, and strong collections.
2 mins
January 09, 2026
Business Standard
Govt steps up efforts to attract FDI for GCCs, semicon units
In pursuit of its $1 trillion economy goal, the Uttar Pradesh (UP) government is stepping up efforts to attract foreign direct investment (FDI) in the Global Capability Centres (GCC) and semiconductor plants.
1 min
January 09, 2026
Business Standard
Health sector seeks tax relief, rationalised rates
Health care, medtech, and pharma companies have urged the government to use the Union Budget 2026-27 to ease tax pressures, boost domestic manufacturing, and step up investments in research, innovation, and preventive care.
2 mins
January 09, 2026
Listen
Translate
Change font size